0001851734-22-000651.txt : 20221109 0001851734-22-000651.hdr.sgml : 20221109 20221109160828 ACCESSION NUMBER: 0001851734-22-000651 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221109 DATE AS OF CHANGE: 20221109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WRAP TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001702924 STANDARD INDUSTRIAL CLASSIFICATION: ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480] IRS NUMBER: 980551945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38750 FILM NUMBER: 221372610 BUSINESS ADDRESS: STREET 1: 1817 W 4TH STREET CITY: TEMPE STATE: AZ ZIP: 85281 BUSINESS PHONE: 800-583-2652 MAIL ADDRESS: STREET 1: 1817 W 4TH STREET CITY: TEMPE STATE: AZ ZIP: 85281 10-Q 1 wrap20220930_10q.htm FORM 10-Q wrap20220930_10q.htm
0001702924 false --12-31 2022 FY 3 2 2 1 2 1 1,302 0 0 0 1 0 0 0 0 00017029242022-01-012022-09-30 00017029242022-11-09 xbrli:shares thunderdome:item iso4217:USD 0001702924wrap:InternationalGovernmentAgencyMemberus-gaap:SubsequentEventMember2022-10-11 00017029242021-01-012021-09-30 00017029242021-07-012021-09-30 00017029242022-07-012022-09-30 0001702924srt:AsiaPacificMember2021-01-012021-09-30 0001702924srt:AsiaPacificMember2022-01-012022-09-30 0001702924srt:AsiaPacificMember2021-07-012021-09-30 0001702924srt:AsiaPacificMember2022-07-012022-09-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2021-01-012021-09-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2022-01-012022-09-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2021-07-012021-09-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2022-07-012022-09-30 0001702924srt:AmericasMember2021-01-012021-09-30 0001702924srt:AmericasMember2022-01-012022-09-30 0001702924srt:AmericasMember2021-07-012021-09-30 0001702924srt:AmericasMember2022-07-012022-09-30 xbrli:pure 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorThreeMember2021-01-012021-12-31 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2021-01-012021-12-31 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2021-01-012021-12-31 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2021-01-012021-12-31 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2022-01-012022-09-30 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2022-01-012022-09-30 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2022-01-012022-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2021-01-012021-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2021-01-012021-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2021-01-012021-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2022-01-012022-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2022-01-012022-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2021-07-012021-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2021-07-012021-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2021-07-012021-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2022-07-012022-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2022-07-012022-09-30 0001702924wrap:MrElwoodNorrisMember2022-01-012022-09-30 00017029242022-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2021-01-012021-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2021-07-012021-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2022-01-012022-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2022-07-012022-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2016-09-30 utr:Y 0001702924us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMember2022-09-30 0001702924us-gaap:EmployeeStockOptionMember2022-01-012022-09-30 0001702924us-gaap:EmployeeStockOptionMember2022-09-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-09-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-09-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2021-07-012021-09-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-09-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-07-012021-09-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2021-01-012021-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2021-07-012021-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2022-01-012022-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2022-07-012022-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-04-30 iso4217:USDxbrli:shares 0001702924us-gaap:RestrictedStockUnitsRSUMember2021-12-31 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2021-01-012021-09-30 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2021-07-012021-09-30 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2022-01-012022-09-30 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2022-07-012022-09-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMembersrt:MaximumMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMembersrt:MinimumMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-30 0001702924us-gaap:EmployeeStockOptionMember2021-01-012021-09-30 0001702924wrap:EmploymentInducementGrantMember2022-04-012022-04-30 0001702924wrap:ServicebasedOptionsMemberwrap:The2017StockIncentivePlanMember2022-09-30 00017029242021-01-012021-12-31 00017029242021-12-31 0001702924wrap:The2017StockIncentivePlanMember2022-01-012022-01-31 0001702924wrap:The2017StockIncentivePlanMember2022-09-30 0001702924wrap:The2017StockIncentivePlanMember2022-06-30 0001702924wrap:The2017StockIncentivePlanMember2022-06-012022-06-30 0001702924wrap:The2017StockIncentivePlanMember2021-06-012021-06-30 0001702924wrap:The2017StockIncentivePlanMember2020-06-012020-06-30 0001702924wrap:The2017StockIncentivePlanMember2019-05-012019-05-31 0001702924wrap:The2017StockIncentivePlanMember2017-03-31 00017029242021-09-30 00017029242020-12-31 0001702924wrap:FormerCeoPayableMember2022-09-30 0001702924wrap:SyzygyLicensingLLCMember2021-12-31 0001702924wrap:SyzygyLicensingLLCMember2022-09-30 0001702924us-gaap:OtherIntangibleAssetsMember2021-12-31 0001702924us-gaap:OtherIntangibleAssetsMember2022-09-30 0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2021-12-31 0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2022-09-30 0001702924us-gaap:TrademarksMember2021-12-31 0001702924us-gaap:TrademarksMember2022-09-30 0001702924us-gaap:PatentsMember2021-12-31 0001702924us-gaap:PatentsMember2022-09-30 0001702924us-gaap:FurnitureAndFixturesMember2021-12-31 0001702924us-gaap:FurnitureAndFixturesMember2022-09-30 0001702924us-gaap:ComputerEquipmentMember2021-12-31 0001702924us-gaap:ComputerEquipmentMember2022-09-30 0001702924wrap:ToolingMember2021-12-31 0001702924wrap:ToolingMember2022-09-30 0001702924wrap:ProductionAndLabEquipmentMember2021-12-31 0001702924wrap:ProductionAndLabEquipmentMember2022-09-30 0001702924us-gaap:FairValueInputsLevel1Member2021-12-31 0001702924us-gaap:FairValueInputsLevel1Member2021-01-012021-12-31 0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2021-12-31 0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2021-01-012021-12-31 0001702924wrap:MoneyMarketFundMemberus-gaap:FairValueInputsLevel1Member2021-12-31 0001702924wrap:MoneyMarketFundMemberus-gaap:FairValueInputsLevel1Member2021-01-012021-12-31 0001702924us-gaap:FairValueInputsLevel1Member2022-09-30 0001702924us-gaap:FairValueInputsLevel1Member2022-01-012022-09-30 0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2022-09-30 0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2022-01-012022-09-30 0001702924wrap:MoneyMarketFundMemberus-gaap:FairValueInputsLevel1Member2022-09-30 0001702924wrap:MoneyMarketFundMemberus-gaap:FairValueInputsLevel1Member2022-01-012022-09-30 0001702924wrap:ExtendedProductWarrantiesMember2021-12-31 0001702924wrap:VirtualRealityTrainingMember2021-12-31 0001702924wrap:ExtendedProductWarrantiesMember2022-09-30 0001702924wrap:VirtualRealityTrainingMember2022-09-30 0001702924wrap:DeferredRevenueMember2022-09-30 0001702924wrap:CustomerDepositsMember2022-09-30 0001702924wrap:DeferredRevenueMember2022-01-012022-09-30 0001702924wrap:CustomerDepositsMember2022-01-012022-09-30 0001702924wrap:DeferredRevenueMember2021-12-31 0001702924wrap:CustomerDepositsMember2021-12-31 0001702924wrap:IntangiblesOtherThanPatentsAndTrademarksMember2021-01-012021-09-30 0001702924wrap:IntangiblesOtherThanPatentsAndTrademarksMember2022-01-012022-09-30 0001702924wrap:PatentsAndTrademarksMember2021-01-012021-09-30 0001702924wrap:PatentsAndTrademarksMember2022-01-012022-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-30 0001702924us-gaap:RetainedEarningsMember2021-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2021-09-30 0001702924us-gaap:CommonStockMember2021-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-30 0001702924us-gaap:RetainedEarningsMember2021-01-012021-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-30 0001702924us-gaap:CommonStockMember2021-01-012021-09-30 0001702924wrap:WarrantsAt8125PerShareMember2021-01-012021-09-30 0001702924wrap:WarrantsAt8125PerShareMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-30 0001702924wrap:WarrantsAt8125PerShareMemberus-gaap:RetainedEarningsMember2021-01-012021-09-30 0001702924wrap:WarrantsAt8125PerShareMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-30 0001702924wrap:WarrantsAt8125PerShareMemberus-gaap:CommonStockMember2021-01-012021-09-30 0001702924wrap:WarrantsAt8125PerShareMember2021-09-30 0001702924wrap:WarrantsAt650PerShareMember2021-01-012021-09-30 0001702924wrap:WarrantsAt650PerShareMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-30 0001702924wrap:WarrantsAt650PerShareMemberus-gaap:RetainedEarningsMember2021-01-012021-09-30 0001702924wrap:WarrantsAt650PerShareMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-30 0001702924wrap:WarrantsAt650PerShareMemberus-gaap:CommonStockMember2021-01-012021-09-30 0001702924wrap:WarrantsAt650PerShareMember2021-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-31 0001702924us-gaap:RetainedEarningsMember2020-12-31 0001702924us-gaap:AdditionalPaidInCapitalMember2020-12-31 0001702924us-gaap:CommonStockMember2020-12-31 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-30 0001702924us-gaap:RetainedEarningsMember2021-07-012021-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-30 0001702924us-gaap:CommonStockMember2021-07-012021-09-30 00017029242021-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-30 0001702924us-gaap:RetainedEarningsMember2021-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2021-06-30 0001702924us-gaap:CommonStockMember2021-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-30 0001702924us-gaap:RetainedEarningsMember2022-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-09-30 0001702924us-gaap:CommonStockMember2022-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-30 0001702924us-gaap:RetainedEarningsMember2022-01-012022-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-30 0001702924us-gaap:CommonStockMember2022-01-012022-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-31 0001702924us-gaap:RetainedEarningsMember2021-12-31 0001702924us-gaap:AdditionalPaidInCapitalMember2021-12-31 0001702924us-gaap:CommonStockMember2021-12-31 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-30 0001702924us-gaap:RetainedEarningsMember2022-07-012022-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-30 0001702924us-gaap:CommonStockMember2022-07-012022-09-30 00017029242022-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-30 0001702924us-gaap:RetainedEarningsMember2022-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-06-30 0001702924us-gaap:CommonStockMember2022-06-30
 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2022

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to _________

 

Commission File Number: 000-55838

 

wrap20220930_10qimg001.jpg

 

Wrap Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

98-0551945

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

1817 W 4th Street

Tempe, Arizona 85281

(Address of principal executive offices) (Zip Code)

 

(800) 583-2652

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

WRAP

Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   ☒ Yes   ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer        ☐

 

Accelerated filer                     ☐

Non-accelerated filer            ☒

 

Smaller reporting company    

   

Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No ☒

 

As of November 9, 2022 a total of 41,124,312 shares of the Registrant’s common stock, par value $0.0001, (“Common Stock”) were issued and outstanding.

 

 

 

 

WRAP TECHNOLOGIES, INC.

 

INDEX

 

PART I. FINANCIAL INFORMATION

   
     

Item 1.

Financial Statements:

   
 

Condensed Consolidated Balance Sheets as of September 30, 2022 (unaudited) and December 31, 2021

  1
 

Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2022 and 2021 (unaudited)

  2
 

Condensed Consolidated Statements of Stockholders Equity for the three and nine months ended September 30, 2022 and 2021 (unaudited)

  3
 

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 (unaudited)

  5
 

Notes to Unaudited Condensed Consolidated Interim Financial Statements

  6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  16

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

  27

Item 4.

Controls and Procedures

  28
       

PART II. OTHER INFORMATION

   
       

Item 1.

Legal Proceedings

  28

Item 1A.

Risk Factors

  29

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

  29

Item 3.

Defaults Upon Senior Securities

  29

Item 4.

Mine Safety Disclosures

  29

Item 5.

Other Information

  29

Item 6.

Exhibits

  29
       

SIGNATURES

    30

 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

Wrap Technologies, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except par value and share amounts)

 

   

September 30,

         
   

2022

   

December 31,

 
   

(Unaudited)

   

2021

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 3,828     $ 4,937  

Short-term investments

    19,865       29,983  

Accounts receivable and contract assets, net

    2,222       3,859  

Inventories, net

    2,962       1,566  

Prepaid expenses and other current assets

    600       868  

Total current assets

    29,477       41,213  

Property and equipment, net

    819       976  

Operating lease right-of-use asset, net

    311       51  

Intangible assets, net

    1,900       1,982  

Other assets

    11       9  

Total assets

  $ 32,518     $ 44,231  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current liabilities:

               

Accounts payable

  $ 945     $ 1,779  

Accrued liabilities

    991       824  

Customer deposits

    -       43  

Deferred revenue- short term

    144       155  

Operating lease liability - short term

    106       56  

Total current liabilities

    2,186       2,857  
                 

Long-term liabilities:

               

Deferred revenue- long term

    156       110  

Operating lease liability - long term

    221       -  

Total long-term liabilities

    377       110  

Total liabilities

    2,563       2,967  
                 

Commitments and contingencies (Note 11)

               
                 

Stockholders' equity:

               

Preferred stock - 5,000,000 authorized; par value $0.0001 per share; none issued and outstanding

    -       -  

Common stock - 150,000,000 authorized; par value $0.0001 per share; 41,125,578 and 40,851,945 shares issued and outstanding each period, respectively

    4       4  

Additional paid-in capital

    93,736       91,025  

Accumulated deficit

    (63,841 )     (49,759 )

Accumulated other comprehensive loss

    56       (6 )

Total stockholders' equity

    29,955       41,264  

Total liabilities and stockholders' equity

  $ 32,518     $ 44,231  

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

 

 

 

Wrap Technologies, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share amounts)

(unaudited)

 

   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
   

2022

   

2021

   

2022

   

2021

 
Revenues:                                

Product sales

  $ 1,612     $ 1,719     $ 4,042     $ 4,997  

Other revenue

    89       86       422       283  

Total revenues

    1,701       1,805       4,464       5,280  
Cost of revenues:                                

Products and services

    790       1,094       2,430       3,276  

Product line exit expense

    -       -       -       747  

Total cost of revenues

    790       1,094       2,430       4,023  

Gross profit

    911       711       2,034       1,257  
                                 
Operating expenses:                                

Selling, general and administrative

    3,586       4,654       11,952       16,210  

Research and development

    1,236       2,076       4,210       4,303  

Total operating expenses

    4,822       6,730       16,162       20,513  

Loss from operations

    (3,911 )     (6,019 )     (14,128 )     (19,256 )
                                 
Other income (expense):                                

Investment income

    34       13       36       22  

Other

    12       15       10       14  
      46       28       46       36  

Net loss

  $ (3,865 )   $ (5,991 )   $ (14,082 )   $ (19,220 )
                                 

Net loss per basic and diluted common share

  $ (0.09 )   $ (0.15 )   $ (0.34 )   $ (0.50 )

Weighted average common shares used to compute net loss per basic and diluted common share

    41,086,285       40,413,332       40,955,234       38,767,009  
                                 
Comprehensive loss:                                

Net loss

  $ (3,865 )   $ (5,991 )   $ (14,082 )   $ (19,220 )

Net unrealized gain (loss) on short-term investments

    73       (2 )     62       (4 )

Comprehensive loss

  $ (3,792 )   $ (5,993 )   $ (14,020 )   $ (19,224 )

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

 

 

Wrap Technologies, Inc.

Condensed Consolidated Statements of Stockholders' Equity

(in thousands, except share amounts)

(unaudited)

 

   

Three Months Ended September 30, 2022

 
                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
   

Common Stock

           

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at July 1, 2022

    40,992,161     $ 4     $ 92,856     $ (59,976 )   $ (17 )   $ 32,867  

Common shares issued upon exercise of stock options

    5,500       -       8       -       -       8  

Share-based compensation expense

    -       -       872       -       -       872  

Common shares issued upon vesting of restricted stock units

    127,917       -       -       -       -       -  

Net unrealized gain on short-term investments

    -       -       -       -       73       73  

Net loss for the period

    -       -       -       (3,865 )     -       (3,865 )

Balance at September 30, 2022

    41,125,578     $ 4     $ 93,736     $ (63,841 )   $ 56     $ 29,955  

 

 

   

Nine Months Ended September 30, 2022

 
                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
   

Common Stock

           

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at January 1, 2022

    40,851,945     $ 4     $ 91,025     $ (49,759 )   $ (6 )   $ 41,264  

Common shares issued upon exercise of stock options

    55,500       -       83       -       -       83  

Share-based compensation expense

    -       -       2,628       -       -       2,628  

Common shares issued upon vesting of restricted stock units

    218,133       -       -       -       -       -  

Net unrealized gain on short-term investments

    -       -       -       -       62       62  

Net loss for the period

    -       -       -       (14,082 )     -       (14,082 )

Balance at September 30, 2022

    41,125,578     $ 4     $ 93,736     $ (63,841 )   $ 56     $ 29,955  

 

 

   

Three Months Ended September 30, 2021

 
                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
   

Common Stock

           

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at July 1, 2021

    39,911,390     $ 4     $ 87,277     $ (38,539

)

  $ 13     $ 48,755  

Common shares issued upon exercise of stock options

    758,338       -       1,399       -       -       1,399  

Common shares issued upon vesting of restricted stock units

    79,133       -       -       -       -       -  

Share-based compensation expense

    -       -       1,303       -       -       1,303  

Net unrealized loss on short-term investments

    -       -       -       -       (2 )     (2 )

Net loss for the period

    -       -       -       (5,991 )     -       (5,991 )

Balance at September 30, 2021

    40,748,861     $ 4     $ 89,979     $ (44,530 )   $ 11     $ 45,464  

 

 

   

Nine Months Ended September 30, 2021

 
                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
   

Common Stock

   

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at January 1, 2021

    37,554,162     $ 4     $ 71,705     $ (25,310

)

  $ 15     $ 46,414  

Common shares issued upon exercise of warrants at $6.50 per share

    1,661,320       -       10,799       -       -       10,799  

Common shares issued upon exercise of warrants at $8.125 per share

    153,692       -       1,249       -       -       1,249  

Common shares issued upon exercise of stock options

    915,404       -       1,678       -       -       1,678  

Common shares issued upon vesting of restricted stock units

    421,407       -       -       -       -       -  

Common shares issued for services

    42,876       -       239       -       -       239  

Share-based compensation expense

    -       -       4,310       -       -       4,310  

Net unrealized loss on short-term investments

    -       -       -       -       (4 )     (4 )

Net loss for the period

    -       -       -       (19,220 )     -       (19,220 )

Balance at September 30, 2021

    40,748,861     $ 4     $ 89,979     $ (44,530 )   $ 11     $ 45,464  

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

 

 

Wrap Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

   

Nine Months Ended September 30,

 
   

2022

   

2021

 
Cash Flows From Operating Activities:                

Net loss

  $ (14,082 )   $ (19,220 )
Adjustments to reconcile net loss to net cash used in operating activities:                

Depreciation and amortization

    574       336  

Product line exit expense

    -       747  

Gain on sale of assets

    -       (17

)

Warranty provision

    55       23  

Software impairment charge

    -       170  

Change in contingent liability

    -       (23 )

Non-cash lease expense

    75       67  

Share-based compensation

    2,628       4,310  

Common shares issued for services

    -       239  

Provision for doubtful accounts

    61       27  
Changes in assets and liabilities:                

Accounts receivable

    1,576       (1,414 )

Inventories

    (1,396 )     (160 )

Prepaid expenses and other current assets

    268       231  

Accounts payable

    (834 )     271  

Operating lease liability

    (65 )     (71 )

Customer deposits

    (43 )     19  

Accrued liabilities and other

    175       502  

Warranty settlement

    (63 )     10  

Deferred revenue

    35       224  

Net cash used in operating activities

    (11,036 )     (13,729 )
                 
Cash Flows From Investing Activities:                

Purchase of short-term investments

    (23,119 )     (30,014 )

Proceeds from maturities of short-term investments

    33,300       25,000  

Capital expenditures for property and equipment

    (201 )     (811 )

Investment in patents and trademarks

    (133 )     (129 )

Purchase of intangible assets

    -       (561 )

Proceeds from long-term deposits

    (3 )     4  

Net cash provided by (used in) investing activities

    9,844       (6,511 )
                 
Cash Flows From Financing Activities:                

Proceeds from exercise of warrants

    -       12,048  

Proceeds from exercise of stock options

    83       1,678  

Repayment of debt

    -       (275 )

Net cash provided by financing activities

    83       13,451  
                 

Net decrease in cash and cash equivalents

    (1,109 )     (6,789 )

Cash and cash equivalents, beginning of period

    4,937       16,647  

Cash and cash equivalents, end of period

  $ 3,828     $ 9,858  
                 
Supplemental Disclosure of Non-Cash Investing and Financing Activities:                

Change in unrealized gain on short-term investments

  $ 62     $ (2

)

Right-of-use asset and liability recorded during period

  $ 260     $ (66

)

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

 

Wrap Technologies, Inc.

Notes to Unaudited Condensed Consolidated Interim Financial Statements

(in thousands, except per share and share amounts)

 

 

1.                ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization and Business Description

 

Wrap Technologies, Inc., a Delaware corporation (the “Company”, “we”, “us”, and “our”), is a publicly traded company with our Common Stock, par value $0.0001 per share (“Common Stock”), listed on the Nasdaq Capital Market (“Nasdaq”) under the trading symbol “WRAP”. The Company is a developer and supplier of public safety products and training services for law enforcement and security personnel. The Company’s primary product is the BolaWrap® remote restraint device. The principal markets for the Company’s proprietary products and services are in North and South America, Europe, Middle East and Asia.

 

Basis of Presentation

 

The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2021, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (the “Annual Report”), as filed with the SEC on March 10, 2022. The accompanying condensed consolidated balance sheet at December 31, 2021, has been derived from the audited consolidated balance sheet at December 31, 2021, contained in the Annual Report. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.

 

Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.

 

Principles of Consolidation

 

The Company has one wholly-owned subsidiary, Wrap Reality, Inc. formed in December 2020 that sells a virtual reality (“VR”) training system primarily targeting law enforcement agencies. The consolidated financial statements include the accounts of this subsidiary after elimination of intercompany transactions and accounts.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.

 

Loss per Share

 

Basic loss per common share is computed by dividing net loss for the period by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net loss per Common Share reflects the potential dilution of securities that could share in the earnings of an entity. The Company’s losses for the periods presented cause the inclusion of potential Common Stock instruments outstanding to be antidilutive. Stock options and restricted stock units exercisable or issuable for a total of 6,396,277 shares of Common Stock were outstanding at September 30, 2022. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company.

 

 

Recent Issued Accounting Guidance

 

In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), to require that an acquirer recognize, and measure contract assets and contract liabilities acquired in a business combination in accordance with FASB Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“Topic 606”). At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments in ASU 2021-08 should be applied prospectively and are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We do not expect the adoption of ASU 2021-08 to have a material impact on our consolidated financial statements and related disclosures.

 

The Company has reviewed other recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.

 

 

2.          REVENUE AND PRODUCT COSTS

 

On January 1, 2018, the Company adopted Topic 606 and, as it had no prior revenue or contracts with customers, there was no transition required nor any impact on prior results. Topic 606 requires entities to recognize revenue through the application of a five-step model, which includes identification of the contract, identification of the performance obligations, determination of the transaction price, allocation of the transaction price to the performance obligations and recognition of revenue as the entity satisfies the performance obligations.

 

The Company enters into contracts that include various combinations of products, accessories, software and services, each of which are generally distinct and are accounted for as separate performance obligations. Product sales includes BolaWrap products and accessories. Other revenue includes VR revenues, service, training and shipping revenues.

 

A performance obligation is a promise in a contract to transfer a distinct good or service to a customer and is the unit of account in Topic 606. For contracts with a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts with multiple performance obligations, the Company allocates the contract transaction price to each performance obligation using the Company’s estimate of the standalone selling price (“SSP” or “SSPs”) of each distinct good or service in a contract. The Company determines SSPs based on the relative SSP. If the SSP is not observable through past transactions, the Company estimates the SSP considering available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

 

Most of the Company’s products and accessories are sold through domestic and international distributors. Performance obligations to deliver products and accessories are generally satisfied at the point in time the Company ships the product, as this is when the customer obtains control of the asset under our standard terms and conditions. Periodically, certain customers request bill and hold transactions for future delivery as scheduled and designated by them. In such cases, revenue is not recognized until after control, title and risk of ownership has transferred which is generally when the customer has requested such transaction under normal billing and payment terms and has been notified that the product (i) has been completed according to customer specifications, (ii) has passed quality control inspections, and (iii) has been tagged and packed for shipment, separated from other inventory and ready for physical transfer to the customer. The value associated with custodial storage services is deemed immaterial in the context of such contracts and in total, and accordingly, none of the transaction price is allocated to such service.

 

The Company has elected to recognize shipping costs as an expense in cost of revenue when control has transferred to the customer.

 

Time-based VR system contracts generally include setup, training and the use of software and hardware for a fixed term, generally one to five years and support and upgrade services during the same period. The Company does not sell time-based arrangements without setup, training and support services and therefore revenues for the entire arrangement are recognized on a straight-line basis over the term. When hardware is bundled and not sold separately the Company allocates the contract transaction price to each performance obligation using the SSP of each distinct good and service in the contract.

 

 

The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced, and a receivable is recorded. A contract asset is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company may receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below details the activity in our contract liabilities during the nine months ended September 30, 2022.

 

   

Customer

   

Deferred

 
   

Deposits

   

Revenue

 

Balance at January 1, 2022

  $ 43     $ 265  

Additions, net

    -       171  

Transfer to revenue

    (43 )     (136 )

Balance at September 30, 2022

  $ -     $ 300  

Current portion

  $ -     $ 144  

Long-term portion

  $ -     $ 156  

 

At September 30, 2022, the Company’s deferred revenue of $300 consisted of $177 related to VR training and $123 related to BolaWrap extended warranties and services. At December 31, 2021, the Company’s deferred revenue of $265 consisted of $172 related to VR training and $67 related to extended warranties and services. 

 

The Company recognizes an asset if there are incremental costs of obtaining a contract with a customer such as commissions. These costs are ascribed to or allocated to the underlying performance obligations in the contract and amortized consistent with the recognition timing of the revenue for any such underlying performance obligations. The Company had no such assets at September 30, 2022, and December 31 2021. The Company will apply the practical expedient to expense any sales commissions related to performance obligations with an amortization of one year or less when incurred within selling, general and administrative expense.

 

Estimated costs for the Company’s standard warranty, generally one-year, are charged to cost of products sold when revenue is recorded for the related product. Royalties are also charged to cost of products sold.

 

 

3.          FAIR VALUE MEASUREMENTS

 

Assets and liabilities recorded at fair value on a recurring basis in the Condensed Consolidated Balance Sheets and assets and liabilities measured at fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows: 

 

Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

 

Level 2—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and 

 

 

Level 3—Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

 

The Company’s cash equivalent Money Market Funds and short-term investments consisting of U.S. Treasury bill securities are classified as Level I because they are valued using quoted market prices.

 

The following table shows the Company’s cash and cash equivalents, Money Market Funds and short-term investments by significant investment category as of September 30, 2022, and December 31, 2021.

 

   

As of September 30, 2022

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

Money Market Funds

  $ 3,382     $ -     $ -     $ 3,382  

U.S. Treasury securities in short-term investments

    19,803       62       -       19,865  

Total Financial Assets

  $ 23,185     $ 62     $ -     $ 23,247  

 

   

As of December 31, 2021

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

Money Market Funds

  $ 1,670     $ -     $ -     $ 1,670  

U.S. Treasury securities in short-term investments

    29,989       -       (6 )     29,983  

Total Financial Assets

  $ 31,659     $ -     $ (6 )   $ 31,653  

 

Unrealized gains or losses resulting from our short-term investments are recorded in accumulated other comprehensive gain or loss. During the three and nine months ended September 30, 2022, a $73 gain and $62 gain was recorded to accumulated other comprehensive gain (loss), respectively. During the three and nine months ended September 30, 2021, a $2 loss and a $4 loss was recorded to accumulated other comprehensive loss, respectively

 

Our financial instruments also include accounts receivable, accounts payable, accrued liabilities and business acquisition liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheet.

 

 

4.          INVENTORIES, NET

 

Inventory is recorded at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. Inventories consisted of the following:

 

   

September 30,

   

December 31,

 
   

2022

   

2021

 

Finished goods

  $ 1,974     $ 1,027  

Work in process

    -       2  

Raw materials

    988       537  

Inventories, net

  $ 2,962     $ 1,566  

 

 

 

5.          PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following:

 

   

September 30,

   

December 31,

 
   

2022

   

2021

 

Production and lab equipment

  $ 500     $ 500  

Tooling

    424       273  

Computer equipment

    513       467  

Furniture, fixtures and improvements

    181       176  
      1,618       1,416  

Accumulated depreciation

    (799 )     (440 )

Property and equipment, net

  $ 819     $ 976  

 

Depreciation expense was $121 and $359 for the three and nine months ended September 30, 2022 and was $69 and $191 for the three and nine months ended September 30, 2021, respectively.

 

 

6.          INTANGIBLE ASSETS, NET

 

Intangible assets consisted of the following:

 

   

September 30,

   

December 31,

 
   

2022

   

2021

 

Amortizable intangible assets:

               

Patents

  $ 540     $ 416  

Trademarks

    143       134  

Purchased software

    1,212       1,212  

Other

    50       50  
      1,945       1,812  

Accumulated amortization

    (389 )     (174 )

Total amortizable

    1,556       1,638  

Indefinite life assets (non-amortizable)

    344       344  

Total intangible assets, net

  $ 1,900     $ 1,982  

 

Amortization expense was $72 and $215 for the three and nine months ended September 30, 2022 and was $48 and $145 for the three and nine months ended September 30, 2021, respectively.

 

At September 30, 2022, future amortization expense is as follows:

 

2022 (3 months)

  $ 72  

2023

    284  

2024

    284  

2025

    280  

2026

    192  

Thereafter

    444  

Total estimated amortization expense

  $ 1,556  

 

 

7.          ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Accounts payable includes $61 and $228 due to related party Syzygy Licensing, LLC (“Syzygy”) as of September 30, 2022, and December 31, 2021, respectively. See Notes 10, 11, and 12 for additional related party information.

 

Accrued liabilities consist of the following:

 

   

September 30,

   

December 31,

 
   

2022

   

2021

 

Patent and legal costs

  $ 131     $ 28  

Accrued compensation

    759       628  

Warranty costs

    88       96  

Taxes and other

    13       72  
    $ 991     $ 824  

 

 

Accrued compensation includes $25 of future severance payments for the Company’s former Chief Executive Officer payable through October 2022.

 

Changes in our estimated product warranty costs were as follows:

 

   

Nine months Ended September 30,

 
   

2022

   

2021

 

Balance, beginning of period

  $ 96     $ 48  

Warranty settlements

    (63 )     (16 )

Warranty provision

    55       42  

Balance, end of period

  $ 88     $ 74  

 

 

8.          LEASES

 

The Company determines if an arrangement is a lease at inception. The guidance in FASB ASC Topic 842, Leases defines a lease as a contract, or part of a contract, that conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. Operating lease right of use (ROU”) assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. The Company’s leases do not provide an implicit rate. Due to a lack of financing history or ability, the Company uses an estimate of low-grade debt rate published by the Federal Reserve Bank as its incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The ROU asset includes any lease payments made and excludes lease incentives and initial direct costs incurred.

 

For leases beginning on or after January 1, 2019, lease components are accounted for separately from non-lease components for all asset classes. On January 21, 2022, the Company’s lease was amended to extend the expiration date to July 31, 2025. Upon execution of the amendment, which was deemed a lease modification, the Company reassessed the lease liability using the discount rate determined at the modification date and recorded an additional ROU asset for the same amount. The Company’s lease contains renewal provisions and escalating rental clauses and generally require the Company to pay utilities, insurance, taxes and other operating expenses. The renewal provisions of the existing lease agreement was not included in the determination of the operating lease liabilities and the ROU assets. The Company also reassessed the lease classification and concluded that the lease continues to be an operating lease.

 

Amortization of ROU operating lease assets was $26 and $75 for the three and nine months ended September 30, 2022 and was $21 and $67 for the three and nine months ended September 30, 2021, respectively.

 

Operating lease expense for capitalized operating leases included in operating activities was $30 and $88 for the three and nine months ended September 30, 2022 and was $23 and $73 for the three and nine months ended September 30, 2021, respectively. 

 

Operating lease obligations recorded on the balance sheet at September 30, 2022, are:

 

Operating lease liability- short term

  $ 106  

Operating lease liability - long term

    221  

Total Operating Lease Liability

  $ 327  

 

 

Future lease payments included in the measurement of lease liabilities on the balance sheet at September 30, 2022, for future periods are as follows:

 

2022 (3 months)

  $ 31  

2023

    121  

2024

    125  

2025

    75  

Total future minimum lease payments

    352  

Less imputed interest

    (25 )

Total

  $ 327  

 

The weighted average remaining lease term is 2.83 years, and the weighted average discount rate is 5.0%.

 

The Company had $3 and $0 short-term lease expense during the nine months ended September 30, 2022, and 2021. The Company does not have any finance leases.

 

 

9.          STOCKHOLDERS' EQUITY

 

The Company’s authorized capital consists of 150,000,000 shares of Common Stock, par value $0.0001 per share, and 5,000,000 shares of preferred stock, par value $0.0001 per share (“Preferred Stock”).

 

At December 31, 2021 the Company had outstanding Common Stock purchase warrants exercisable for 1,391,667 shares that expired on June 1, 2022, and had no purchase warrants outstanding at September 30, 2022.

 

 

10.          SHARE-BASED COMPENSATION

 

On March 31, 2017, the Company adopted, and the stockholders approved, the 2017 Stock Incentive Plan (the “Plan”) authorizing 2,000,000 shares of Common Stock for issuance as awards to employees, directors or consultants. In May 2019, the stockholders ratified an increase in the Plan authorizing an additional 2,100,000 shares of Common Stock, in June 2020 ratified an additional 1,900,000 shares of Common Stock, in June 2021 ratified an additional 1,500,000 shares of Common Stock and in June 2022 ratified an additional 1,500,000 shares of Common Stock, for a total of 9,000,000 shares subject to the Plan. At September 30, 2022, there were 1,624,160 shares of Common Stock remaining available for grant under the Plan.

 

The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. In January 2022 the Company recognized severance acceleration of $242 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer as part of a management transition plan.

 

Stock Options

 

The following table summarizes stock option activity for the nine months ended September 30, 2022:

 

           

Weighted Average

         
   

Options on

           

Remaining

   

Aggregate

 
   

Common

   

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term

   

Value

 

Outstanding January 1, 2022

    3,935,883     $ 5.24       4.79          

Granted

    2,734,639     $ 2.85                  

Exercised

    (55,500 )   $ 1.50                  

Forfeited, cancelled, expired

    (978,709 )   $ 5.48                  

Outstanding September 30, 2022

    5,636,313     $ 3.74       6.01     $ 232,778  

Exercisable September 30, 2022

    2,507,744     $ 4.47       2.14     $ 232,778  

 

At September 30, 2022, there were 4,022,083 service-based stock options outstanding, and 1,614,230 performance-based stock options outstanding, which performance-based stock options were granted in April 2022 to the Company’s Chief Executive Officer and President, subject to future market capitalization targets. 1,049,145 of the 4,013,885 stock options granted included in the table above were granted in April 2022 outside the Plan as an employment inducement grant, but are subject to the terms and conditions of the Plan.

 

 

The Company uses the Black-Scholes option pricing model to determine the fair value of service-based options granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees:

 

   

For the Nine months

 
   

Ended September 30,

 
   

2022

   

2021

 

Expected stock price volatility

   

49

%

   

50

%

Risk-free interest rate

   

1.17

%

   

0.90

%

Expected dividend yield

   

0

%

   

0

%

Expected life of options - years

   

3.46

     

5.74

 

Weighted-average fair value of options granted

  $

1.25

    $

2.57

 

 

Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of awards. The Company’s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred.

 

The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of zero is based on the fact that the Company has never paid cash dividends and has no present intention to pay cash dividends. The Company calculates the expected life of the options using the Simplified Method for the employee stock options as the Company does not have sufficient historical exercise data.

 

The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of 1,614,230 market condition performance options granted in April 2022 to the Company’s newly appointed Chief Executive Officer and a newly appointed President. The assumptions used in the Monte Carlo Simulation were stock price on date of grant of $2.89, contract term of 10 years, expected volatility of 49% and risk-free interest rate of 2.9%. Vesting is based on sustained market capitalization of $250 million, $500 million and $1 billion and resulted in implied service periods ranging from approximately 4 to 7 years.

 

Stock option expense was $308 and $1,448 for the three and nine months ended September 30, 2022 and was $1.302 and $4,310 for the three and nine months ended September 30, 2021, respectively.

 

Restricted Stock Units

 

The Plan provides for the grant of restricted stock units (“RSUs”). RSUs are settled in shares of the Company’s Common Stock as the RSUs become vested. The following table summarizes RSU activity for the nine months ended September 30, 2022:

 

           

Weighted Average

   

Weighted Average

 
   

Service-Based

   

Grant Date

   

Vesting

 
   

RSU's

   

Fair Value

   

Period (Years)

 

Unvested at January 1, 2022

    269,303     $ 6.47          

Granted - service based

    753,817     $ 2.57          

Vested

    (218,133 )   $ 4.93          

Forfeited and cancelled

    (60,023 )   $ 6.57          

Unvested at September 30, 2022

    744,964     $ 2.97       2.32  

 

A total of 175,173 RSUs included in the table above were granted in April 2022 outside the Plan as an employment inducement grant but are subject to the terms and conditions of the Plan.

 

 

RSU expense was $564 and $1,180 for the three and nine months ended September 30, 2022 and was $467 and $2,245 for the three and nine months ended September 30, 2021, respectively.

 

Share-Based Compensation Expense

 

The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows:

 

   

Three Months Ended

September 30,

   

Nine months Ended

September 30,

 
   

2022

   

2021

   

2022

   

2021

 

Selling, general and administrative

  $ 700     $ 1,093     $ 2,180     $ 3,722  

Research and development

    172       210       448       588  

Total share-based expense

  $ 872     $ 1,303     $ 2,628     $ 4,310  

 

As of September 30, 2022, total estimated compensation expense of stock options granted and outstanding but not yet vested was $3,820 which is expected to be recognized over the weighted average period of 3.5 years. As of September 30, 2022, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $1,828 which is expected to be recognized over the weighted average period of 2.3 years.

 

 

11.          COMMITMENTS AND CONTINGENCIES

 

Facility Lease

 

See Note 8.

 

Related Party Technology License Agreement

 

The Company is obligated to pay royalties and development and patent costs pursuant to an exclusive Amended and Restated Intellectual Property License Agreement dated as of September 30, 2016, with Syzygy, a company owned and controlled by stockholder/consultant Mr. Elwood Norris and stockholder/consultant Mr. James Barnes. The agreement provides for royalty payments of 4% of revenue from products employing the licensed ensnarement device technology up to an aggregate of $1,000 in royalties or until September 30, 2026, whichever occurs earlier. The Company recorded $61 and $147 for royalties during the three and nine months ended September 30, 2022 and $65 and $185 incurred for the three and nine months ended September 30, 2021, respectively.

 

Purchase Commitments

 

At September 30, 2022, the Company was committed for approximately $4,376 for future component deliveries that are generally subject to modification or rescheduling in the normal course of business.

 

 

12.          RELATED PARTY TRANSACTIONS

 

Commencing in October 2017 the Company began reimbursing Mr. Elwood Norris, a former officer and current stockholder and consultant of the Company, $1.5 per month on a month-to-month basis for laboratory facility expense, for an aggregate of $13.5 during the nine months ended September 30, 2022, and 2021, respectively.

 

See Notes 7, 10 and 11 for additional information on related party transactions and obligations.

 

 

13.          MAJOR CUSTOMERS AND RELATED INFORMATION

 

For the three months ended September 30, 2022, revenues from one distributor accounted for approximately 59%, of revenues with no other single customer accounting for more than 10% of total revenues. For the three months ended September 30, 2021, revenues from two distributors accounted for approximately 41% and 29% of revenues with no other single customer accounting for more than 10% of total revenues.

 

 

For the nine months ended September 30, 2022, revenues from one distributor accounted for approximately 39% of revenues with no other single customer accounting for more than 10% of total revenues. For the nine months ended September 30, 2021, revenues from two distributors accounted for approximately 27% and 21% of revenues with no other single customer accounting for more than 10% of total revenues.

 

At September 30, 2022, accounts receivable from two distributors accounted for 42% and 15% of accounts receivable with no other single customer accounting for more than 10% of the accounts receivable balance. Three distributors accounted for 48%, 16% and 15% of accounts receivable at December 31, 2021 with no other single customer accounting for more than 10% of the accounts receivable balance.

 

The following table summarizes revenues by geographic region. Revenues are attributed to countries based on customer’s delivery location:

 

   

For the Three Months

   

For the Nine months

 
   

Ended September 30,

   

Ended September 30,

 
   

2022

   

2021

   

2022

   

2021

 

Americas

  $ 1,478     $ 1,088     $ 3,484     $ 2,837  

Europe, Middle East and Africa

    220       745       435       2,424  

Asia Pacific

    3       (28 )     545      

19

 

Total revenues

  $ 1,701     $ 1,805     $ 4,464     $ 5,280  

 

 

14.          SUBSEQUENT EVENTS

 

On October 11, 2022, the company received an order from an international government agency for the purchase of over 2,000 BolaWrap devices, cassettes and other accessories totaling over $1.5 million. This order will be recorded in the fourth quarter 2022.

 

The Company evaluated subsequent events for their potential impact on the financial statements and disclosures through the date the financial statements were available to be issued, and determined that, except as disclosed herein, no subsequent events occurred that were reasonably expected to impact the financial statements presented herein.

 

 

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

You should read the following discussion in conjunction with the financial statements and other financial information included elsewhere in this Quarterly Report on Form 10-Q (this “Report”) and with our audited financial statements and other information presented in our Annual Report on Form 10-K for the year ended December 31, 2021 (the “Annual Report”). The following discussion may contain forward-looking statements that reflect our plans, estimates and beliefs. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “continue,” “may,” “will,” “could,” “would,” or the negative or plural of such words and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the only means of identifying forward-looking statements. Such forward-looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by the forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, those discussed below and elsewhere in this Report and in our other filings with the Securities and Exchange Commission (“SEC”), including particularly matters set forth under Part I, Item 1A (Risk Factors) of the Annual Report. Furthermore, such forward-looking statements speak only as of the date of this Report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. For purposes of Management's Discussion and Analysis within this Report, all monetary amounts are stated in thousands except for par values and per share amounts, unless otherwise stated.

 

Overview

 

We are a global public safety technology and services company organized in March 2016 delivering modern policing solutions to law enforcement and security personnel. We are a mission-driven organization focused on improving public safety encounters and outcomes. We began sales of our first public safety product, the BolaWrap 100 remote restraint device, in late 2018. In October 2021 we released a new generation product, the BolaWrap 150. The BolaWrap 150 is electronically deployed and is more robust, smaller, lighter and simpler to deploy than the BolaWrap 100 that is being phased out. In 2020 we added a new solution to our public safety technologies, which is our virtual reality (“VR”) training platform – Wrap Reality. Wrap Reality is now sold to law enforcement agencies for simulation training as well as corrections departments for the societal reentry scenarios.

 

The immediate addressable domestic market for our solutions consists of approximately 900,000 full-time sworn law enforcement officers at over 15,300 federal, state and local law enforcement agencies, and over 12 million police officers in over 100 countries. We are also exploring other domestic markets, including military and private security. Our international focus is on countries with the largest police forces. The 100 largest international police agencies are estimated to have over 12.1 million law enforcement personnel. According to 360iResearch, a market research consulting firm, we participate in a segment of the non-lethal products global market expected to grow to $16.1 billion by 2027.

 

We focus our efforts on the following products and services:

 

BolaWrap Remote Restraint Device – is a hand-held remote restraint device that discharges an eight-foot bola style Kevlar tether to entangle an individual at a range of 10-25 feet. BolaWrap assists law enforcement to safely and effectively control encounters early in the use of force continuum without resorting to painful force options.

 

Wrap Reality – is a law enforcement training system employing immersive computer graphics VR with proprietary software-enabled content. It allows up to two participants to enter a simulated training environment simultaneously, and customized weapons controllers enable trainees to engage in strategic decision making along the force continuum.

 

In addition to the United States law enforcement market, we have shipped our restraint products to 53 countries. We have established an active distributor network with 13 domestic distributors representing 50 states and one dealer representing Puerto Rico. We have distribution agreements with 49 international distributors covering 56 countries. We focus significant sales, training and business development efforts to support our global distribution network.

 

We focus significant resources on research and development innovations and continue to enhance our products and plan to introduce new products. We believe we have established a strong branding and market presence globally and have established significant competitive advantages in our markets.

 

 

Management Changes

 

As previously reported in January 2022, the Board of Directors approved and initiated a leadership transition plan to support the next phase of its corporate strategy, which is focused on new leadership diversifying the Company’s suite of products, offerings and services. The transition and corporate strategy included the resignation of our President, Chief Executive Officer and director Thomas P. Smith and the announcement of the planned retirement of our Former Chief Financial Officer, Secretary and Treasurer James A. Barnes, who retired in July 2022 upon the appointment of Chris DeAlmeida as our Chief Financial Officer. After a period of transition managed by Special Transition Committee consisting of directors Scot Cohen and Kim Sentovich and including interim contract executives, on April 18, 2022, the Company appointed TJ Kennedy, a current director, as our Chief Executive Officer and Kevin Mullins as our President. Both Messrs. Kennedy and Mullins have significant leadership experience in public safety technology prior to their appointment. Mr. Mullins is leading go to market functions in the President role.

 

Business Outlook and Challenges

 

Our products and solutions continue to gain worldwide awareness and recognition through social media, media exposure, trade shows, product demonstrations and word of mouth as a result of positive responses from agencies and early adoption and deployment success. We believe Wrap is gaining traction as a recognized global brand, with innovative technology and an initial product foundation achieved through aggressive marketing and public relations. We believe that we have strong market opportunities for our remote restraint and VR solutions throughout the world in the law enforcement and security sectors as a result of increasing demands for less lethal policing and increasing threats posed by non-compliant subjects.

 

We continue to receive field reports of successful BolaWrap usage from law enforcement agencies. Many agencies consider BolaWrap as a very low level, or non-reportable, use of force option and, accordingly, many uses are not reported to us. Others are considered evidence and are also not shared. Some law enforcement agencies have shared bodycam footage of their field uses, some of which we are allowed to use in our marketing activities. We believe increased reports of avoiding escalation will help grow revenues in the future.

 

We believe we have a robust and growing pipeline of market opportunities for our restraint product offering and training services within the law enforcement, military, corrections, and homeland security business sectors domestically and internationally. Social trends demanding more compassionate and safe policing practices are expected to continue to drive our global business. We are pursuing large business prospects internationally and also pursuing business with large police agencies in the U.S. It is difficult to anticipate how long it will take to close these opportunities, or if they will ultimately come to fruition especially given the uncertainty of COVID-19 and social unrest, as discussed below.

 

To support our increased sales and distribution activities we have developed and offer robust training and class materials that certify law enforcement officers and trainers as BolaWrap instructors in the use and limitations of the BolaWrap in conjunction with modern policing tactics for de-escalation of encounters. We believe that law enforcement trainers and officers that have seen demonstrations or have been trained about our products are more supportive of their department’s purchase and deployment of product. As of September 30, 2022, over 1,315 agencies have received BolaWrap training with over 4,390 training officers at those agencies certified as BolaWrap instructors and qualified to train the rest of their departments. This represents a 39% increase in agencies and a 36% increase in training officers as compared to September 30, 2021.

 

Operating expenses in the third fiscal quarter of 2022 reduced by 28% as compared to the third fiscal quarter of 2021. The focus on reducing operating expenses was an immediate focus on the new management team. In the second quarter, our new management team focused on assessing all facets of the business and completed a strategic roadmap to drive long-term growth and produce lasting value for shareholders. Our strategic roadmap is centered on sustainably growing sales through building repeatable domestic BolaWrap sales, ramping international sales on the new BolaWrap 150, and implementing a customer success function expanding existing agencies to full patrol-wide BolaWrap deployment. We also have added a dedicated inside sales function to grow our velocity on new leads.  We will be expanding our distributor and partner relationships, and leveraging product diversification and innovation to catalyze sales growth. A key decision in the strategic roadmap was to improve our pricing on BolaWrap 150 devices and cassettes now that the product has proven itself to law enforcement as a significant upgrade. We have also transitioned to charging for our respected training services. We have implemented changes to how we sell Wrap Reality and have now solidified our go forward virtual reality model as a Software as a Service (“SaaS”) model. These changes will have significant positive impact on our future success and growth.

 

 

We firmly believe that focusing on these strategic changes can drive significant sales growth and put us on a path to sustainable profitability. Management intends to execute on its strategic roadmap immediately driving changes in Q3. While geopolitical tensions and macroeconomic headwinds have impacted us in recent quarters, we remain uniquely positioned to deliver best-in-class technologies and data-driven services that can empower law enforcement officers across the globe to have safe, effective encounters with minimal use of force. Wrap has a distinct value proposition in a growing addressable market. Now with improved pricing, reduced operating expenses, and by growing future sales we expect to have reduced losses and improved cash flow.

 

We are recovering from supply chain impacts and a difficult transition from the BolaWrap 100 to the BolaWrap 150. We expect to make more product demonstrations and conduct more training sessions, especially in international markets, as pandemic-related restrictions continue to ease in 2022. We also expect to see increased sales momentum in the back half of 2022 internationally as we raise awareness of all of the BolaWrap 150 enhancements and transition countries to the BolaWrap 150. Lastly, we anticipate discount and promotional costs to decline after Q3 as we have phase out upgrade offers and prioritize growing brand awareness.  

 

Looking beyond 2022, we expect to continue to see strong sales growth of the BolaWrap 150 and Wrap Reality.  This coupled with continued cost savings and cost control, should lead to a continuing reduction of cash burn going forward.  As a result, we anticipate moving to a cash flow break-even point by the end of fiscal 2023, and we anticipate strong sales could lead to profitability by the end of 2024.

 

With the acquisition of NSENA in December 2020, and the rebranding of the NSENA business as Wrap Reality, we have continued to market our VR system while working to integrate previous scenarios into a robust platform, employing BolaWrap and additional de-escalation techniques into new Wrap Reality scenarios. The improved law enforcement simulator platform continues to be used by additional agencies. In July 2022 we announced new wins with large correction agencies in Ohio and Pennsylvania that introduced our new scenarios focused on societal reentry and preventing recidivism. We plan to increase marketing activities for our VR solution to both law enforcement and corrections.

 

On September 30, 2022, we had backlog of approximately $26 thousand expected to be delivered in the next twelve months. Additionally, we had deferred revenue of $300 thousand expected to be recognized generally over the next five years. Distributor and customer orders for future deliveries are generally subject to modification, rescheduling or in some instances, cancellation, in the normal course of business.

 

Since inception in March 2016, we have generated significant losses from operations and anticipate that we will continue to generate significant losses from operations for the foreseeable future. We believe that we have adequate financial resources to sustain our operations for the next year. In the third quarter of fiscal 2022 we reduced our net loss by more than $2 thousand versus the comparable prior year quarter. Net cash used in operations during the nine months ended September 30, 2022 was $2.8 million less than cash used in operations during the first nine months of the prior year.

 

We expect that we will need to continue to innovate new applications for our public safety technology, develop new products and technologies to meet diverse customer requirements and identify and develop new markets for our products.

 

In March 2020, the World Health Organization ("WHO") classified the COVID-19 outbreak as a pandemic. We believe our sales during the first nine months of 2022 were negatively impacted by the transition to the BolaWrap 150 product and the stopping of our BolaWrap 100 production line and the effects of limited ability to demonstrate and train in 2021 due to the COVID-19 pandemic, especially internationally. However, we are beginning to see some recovery during Q3 as full production and sales of the BolaWrap 1500 occurred. We continue to monitor developments and assess areas where there is potential for our business to be impacted by the pandemic. Businesses and governments with which we engage may be operating under restrictions and experiencing disruptions, which may create obstacles in the coordination of business activities, including demonstrations, training and the negotiation and fulfillment of orders. Disruptions in the supply chain have already impacted us and could negatively impact our ability to source materials or manufacture and distribute products. We could experience a decrease in new orders from pandemic related events, which could negatively impact our revenues and reduce our liquidity and cash flows. Growth in revenue could also be impeded by these factors. The financial markets have been subject to significant volatility that could impact our ability to enter into, modify, and negotiate favorable terms and conditions relative to equity and debt financing activities. We have $23.7 million in cash and cash equivalents and short-term investments as of September 30, 2022, which we believe provides sufficient capital to fund our operations for at least the next twelve months and withstand the potential near-term consequences of the pandemic, although liquidity constraints and access to capital markets could adversely impact our liquidity and warrant changes to our investment strategy. The full magnitude of the pandemic cannot be measured at this time, and therefore, any of the aforementioned circumstances, as well as other factors, may cause our results of operations to vary substantially from year to year and quarter to quarter.

 

 

Based on various standards published to date, we believe the work our employees and associates perform is critical and essential. We are taking a variety of measures to promote the safety and security of our employees while ensuring the availability and functionality of our critical infrastructure. We are following Center for Disease Control and local guidelines regarding COVID-19 safety in the workplace. In addition, the following events related to the COVID-19 pandemic could result in lost or delayed revenue to the Company: limitations on the ability of our suppliers to meet delivery requirements and commitments; limitations on the ability of our employees to perform their work due to illness caused by the pandemic, or local, state or federal orders requiring employees to remain at home; limitations on the ability of carriers to deliver our products to customers; unforeseen deviations from customers or foreign governments restricting the ability to do business; and, limitations on the ability of our customers to pay us on a timely basis, if at all.

 

We also may be adversely affected by continued social unrest, protests against racial inequality, protests against police brutality and movements such as “Defund the Police” and such unrest may be exacerbated by inaccurate information or negative publicity regarding our solutions. Although the negativity of some of these events has been reduced, some of these events may still directly or indirectly affect police agency budgets and funding available to current and potential customers. Participants in these events may also attempt to create the perception that our solutions are contributing to the perceived problems, which may adversely affect us, our business and results of operations, including our revenues, earnings and cash flows from operations.

 

Our business may be impacted by global economic conditions, which have been in recent years, and continue to be, volatile. Geopolitical conflict, such as the recent conflict in Ukraine, and related international economic sanctions and their impact may exacerbate this volatility. Specifically, our revenues and gross margins depend significantly on global economic conditions and the demand by foreign governments and agencies for the BolaWrap in many of our target markets.

 

Changes in management and other key personnel have the potential to improve and disrupt our business, and any such disruption could potentially adversely affect our operations, programs, growth, financial condition or results of operations. Improvements to operations, operating expenses and go to market approaches also have the opportunity to impact the success of the business going forward.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expense, and related disclosure of contingent assets and liabilities. We evaluate our estimates, on an on-going basis, including those estimates related to recognition and measurement of contingencies and accrued expense. We base our estimates on historical experience and on various other assumptions we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

 

As part of the process of preparing our financial statements, we are required to estimate our provision for income taxes. Significant management judgment is required in determining our provision for income taxes, deferred tax assets and liabilities, tax contingencies, unrecognized tax benefits, and any required valuation allowance, including taking into consideration the probability of the tax contingencies being incurred. Management assesses this probability based upon information provided by its tax advisers, its legal advisers and similar tax cases. If later our assessment of the probability of these tax contingencies changes, our accrual for such tax uncertainties may increase or decrease. Our effective tax rate for annual and interim reporting periods could be impacted if uncertain tax positions that are not recognized are settled at an amount which differs from our estimates.

 

 

Some of our accounting policies require higher degrees of judgment than others in their application. These include share-based compensation and contingencies and areas such as revenue recognition, allowance for doubtful accounts, valuation of inventory and intangible assets, estimates of product line exit costs, warranty liabilities and impairments.

 

Revenue Recognition. We sell our products to customers including law enforcement agencies, domestic distributors and international distributors and revenue from such transactions is recognized in the periods that products are shipped (free on board (“FOB”) shipping point) or received by customers (FOB destination), when the fee is fixed or determinable and when collection of resulting receivables is reasonably assured. We identify customer performance obligations, determine the transaction price, allocate the transaction price to the performance obligations and recognize revenue as we satisfy the performance obligations. Our primary performance obligations are products/accessories and VR software licensing or sale. Our customers do not have the right to return product unless the product is found to be defective.

 

Share-Based Compensation. We follow the fair value recognition provisions issued by the Financial Accounting Standards Board (“FASB”) in Accounting Standards Codification (“ASC”) Topic 718, Stock Compensation (“ASC 718”) and we adopted Accounting Standards Update (“ASU”) 2018-07 for share-based transactions with non-employees. Share-based compensation expense recognized includes stock option and restricted stock unit compensation expense. The grant date fair value of stock options is determined using the Black-Scholes option-pricing model. The grant date is the date at which an employer and employee or non-employee reach a mutual understanding of the key terms and conditions of a share-based payment award. The Black-Scholes option-pricing model requires inputs including the market price of the Company’s Common Stock on the date of grant, the term that the stock options are expected to be outstanding, the implied stock volatilities of several publicly traded peers over the expected term of stock options, risk-free interest rate and expected dividend. Each of these inputs is subjective and generally requires significant judgment to determine. The grant date fair value of restricted stock units is based upon the market price of the Company’s Common Stock on the date of the grant. We determine the amount of share-based compensation expense based on awards that we ultimately expect to vest and account for forfeitures as they occur. The fair value of share-based compensation is amortized to compensation expense over the vesting term.

 

Allowance for Doubtful Accounts. Our products are sold to customers in many different markets and geographic locations. We estimate our bad debt reserve on a case-by-case basis and the aging of accounts due to a limited number of customers mostly government agencies or well-established distributors. We base these estimates on many factors including customer credit worthiness, past transaction history with the customer, current economic industry trends and changes in customer payment terms. Our judgments and estimates regarding collectability of accounts receivable have an impact on our financial statements.

 

Valuation of Inventory. Our inventory is comprised of raw materials, assemblies and finished products. We must periodically make judgments and estimates regarding the future utility and carrying value of our inventory. The carrying value of our inventory is periodically reviewed and impairments, if any, are recognized when the expected future benefit from our inventory is less than carrying value.

 

Valuation of Intangible Assets. Intangible assets consisted of (a) capitalized legal fees and filing expense related to obtaining patents and trademarks, (b) customer agreements, tradenames, software, non-solicitation and non-compete agreements acquired in business combinations and valued at fair value at the acquisition date, and (c) the purchase cost of indefinite-lived website domains. We must make judgments and estimates regarding the future utility and carrying value of intangible assets. The carrying values of such assets are periodically reviewed and impairments, if any, are recognized when the expected future benefit to be derived from an individual intangible asset is less than carrying value. This generally could occur when certain assets are no longer consistent with our business strategy and whose expected future value has decreased.

 

Accrued Expense. We establish a warranty reserve based on anticipated warranty claims at the time product revenue is recognized. This reserve requires us to make estimates regarding the amount and costs of warranty repairs we expect to make over a period of time. Factors affecting warranty reserve levels include the number of units sold, anticipated cost of warranty repairs, and anticipated rates of warranty claims. We have very limited history to make such estimates and warranty estimates have an impact on our financial statements. Warranty expense is recorded in cost of revenues. We evaluate the adequacy of this reserve each reporting period.

 

 

We use the recognition criteria of FASB ASC Topic 450-20, Loss Contingencies, to estimate the amount of bonuses when it becomes probable a bonus liability will be incurred and we recognize expense ratably over the service period. We accrue bonus expense each quarter based on estimated year-end results, and then adjust the actual in the fourth quarter based on our final results compared to targets.

 

Historically, our assumptions, judgments and estimates relative to our critical accounting policies have not differed materially from actual results. Other than the planned production change requiring a new estimate of exit expense, there were no significant changes or modification of our critical accounting policies and estimates involving management valuation adjustments affecting our results for the period ended September 30, 2022.

 

Segment and Related Information

 

The Company operates as a single segment. The Company’s chief operating decision maker is its Chief Executive Officer, who manages operations for purposes of allocating resources. Refer to Note 13, Major Customers and Related Information, in our financial statements for further discussion.

 

Operating Expenses

 

Our operating expenses include (i) selling, general and administrative expense, (ii) research and development expense, and in the most recent fiscal quarter, (iii) product line exit expense. Research and development expense is comprised of the costs incurred in performing research and development activities and developing production on our behalf, including compensation and consulting, design and prototype costs, contract services, patent costs and other outside expense. The scope and magnitude of our future research and development expense is difficult to predict at this time and will depend on elections made regarding research projects, staffing levels and outside consulting and contract costs. The future level of selling, general and administrative expense will be dependent on staffing levels, elections regarding expenditures on sales, marketing and customer training, the use of outside resources, public company and regulatory expense, and other factors, some of which are outside of our control.

 

We expect our operating costs will remain at comparable current levels in the near term. We may also incur additional non-cash share-based compensation costs depending on future option and restricted stock unit grants that are impacted by stock prices and other valuation factors. Historical expenditures are not indicative of future expenditures.

 

Results of Operations

 

Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021

 

The following table sets forth for the periods indicated certain items of our condensed consolidated statement of operations. The financial information and the discussion below should be read in conjunction with the financial statements and notes contained in this Report.

 

   

Three Months Ended

September 30,

   

Change

 
   

2022

   

2021

   

$

   

%

 
   

(in thousands, except percentage change)

 

Revenues:

                               

Product sales

  $ 1,612     $ 1,719     $ (107 )     (6% )

Other revenue

    89       86       3       3 %

Total revenues

    1,701       1,805       (104 )     (6% )

Cost of revenues:

                               

Products and services

    790       1,094       (304 )     (28% )

Restructuring inventory charge

    -       -       -       -  

Total cost of revenues

    790       1,094       (304 )     (28% )

Gross profit

    911       711       200       28 %
                                 

Operating expenses:

                               

Selling, general and administrative

    3,586       4,654       (1,068 )     (23% )

Research and development

    1,236       2,076       (840 )     (40% )

Total operating expenses

    4,822       6,730       (1,908 )     (28% )

Loss from operations

  $ (3,911 )   $ (6,019 )   $ 2,108       (35% )

 

 

Revenue

 

We reported net revenue of $1.7 million for the three months ended September 30, 2022, as compared to $1.8 million for the prior year quarter. Domestic revenues increased from $1.1 million for the third quarter of 2021 to $1.3 million for the quarter ended September 30, 2022. International revenues decreased from $717 thousand for the third quarter of 2021 to $375 thousand for the quarter ended September 30, 2022. We incurred discounts of $240 thousand during the three months ended September 30, 2022, primarily as a result of promotional programs designed to encourage domestic customers to upgrade to the BolaWrap 150. These discounts compare to business discounts of $81 thousand in the prior year quarter. We expect selected discounts in the fourth quarter but thereafter a decline to minimal discounts as we have phased out our promotional upgrade offer.

 

International revenues generally consist of larger orders with the end user being large, centralized government agencies. These orders continue to be lumpy and difficult to predict as to both timing and amount. International orders anticipated in the second quarter were delayed due to the change over from the BolaWrap 100 but those orders for BolaWrap 150 are anticipated in future quarters. We believe that revenue during the fiscal year 2022 will still be an increase compared to the revenue recorded during 2021 due to growth of domestic sales and anticipated international orders from a robust pipeline, although no assurances can be given.

 

We incurred product promotional costs of $125 thousand during the quarter ended September 30, 2022, related primarily to BolaWrap 150 demonstration products and the cost of training products and accessories delivered to law enforcement agencies that were expensed as marketing costs. A total of $163 thousand of such product promotional costs were incurred during the prior year quarter. We are responding to increased demand for training as a result of expanded product and brand awareness with more efficient training approaches. With increased successful field use by agencies and greater brand awareness, as well as the transition to the BolaWrap 150, we expect reductions in product promotional costs to decline versus the prior year.

 

We had $300 thousand of deferred revenue at September 30, 2022, of which $177 thousand related to VR training and $123 thousand related to BolaWrap extended warranties and services. As we potentially secure increased bookings for Wrap Reality, as well as BolaWrap extended warranties, we expect our deferred revenue to grow in future quarters.

 

At September 30, 2022, we had backlog of $26 thousand worth of customer orders expected to be delivered in the next twelve months. Distributor and customer orders for future deliveries are generally subject to modification, rescheduling or in some instance’s cancellation in the normal course of business.

 

The impact of the COVID-19 pandemic and geopolitical conflicts, including the recent war in Ukraine, has created much uncertainty in the global marketplace. The COVID-19 pandemic has and may continue to restrict our ability to travel internationally. Although no assurances can be given, we do believe, however, that the challenges to substantially increasing sales caused by COVID-19 will abate as the pandemic wanes, especially given the number of BolaWrap trials currently ongoing and the current environment where non-lethal options are being widely considered by law enforcement domestically and internationally. 

 

We have experienced recent changes in management. Changes in management and other key personnel have the potential to disrupt our business, and any such disruption could adversely affect our revenue growth in future periods, especially in the near term as we execute our Management Transition plan.

 

Gross Profit

 

Our cost of revenue for the quarter was $790 thousand resulting in a gross margin of 54%. Our cost of revenue for the three months ended September 30, 2021 was $1,094 thousand resulting in a gross margin of 39%. The most recent quarter period gross margin was impacted by the lower sales volume, warranty costs and promotional discounts. We also were impacted by certain higher raw material prices in the second quarter to obtain certain parts. Our margin is expected to improve in future quarters as these issues abate.

 

 

Due to our limited history of revenue historical margins, however, may not be indicative of planned future margins. The BolaWrap 150 has higher margins than historical production. Our margins also vary based on the sales channels through which our products are sold and product mix. Currently, our cassettes have lower margins than BolaWrap devices. We implement product updates and revisions, including raw material and component changes that may impact product costs. With such product updates and revisions, we have limited warranty cost experience and estimated future warranty costs can impact our gross margins.

 

Our global supply chain has been subject to significant component shortages, increased lead times, cost fluctuations, and logistics constraints that have impacted our product costs. We expect these supply chain challenges to continue throughout 2022. Supplier shortages, quality issues and logistic delays affect our production schedules and could in turn have a material adverse effect on our financial condition, results of operation and cash flows.

 

Selling, General and Administrative Expense

 

Selling, general and administrative (SG&A”) expense for the quarter ended September 30, 2022 were $1.1 million less than the prior year comparable quarter due to cost containment efforts and due to certain one-time costs in the prior year quarter.

 

Share-based compensation costs allocated to SG&A decreased to $700 thousand compared to $1.1 million for the comparable prior quarter. This $393 thousand decrease resulted primarily from a one-time costs in the prior year period and changes in the stock price.

 

Salaries and burden costs of $2.2 million for the quarter ended September 30, 2022 were comparable to the prior year as staffing remained at similar levels. During the quarter ended September 30, 2022, as compared to the prior year comparable quarter, we incurred reduced advertising and promotions costs (including product promotion costs) of $153 thousand, reduced professional fees of $136 thousand, and reduced consulting and contract services fees of $359 thousand. We expect expenditures for SG&A expenses for the balance of 2022 to remain below the prior year due to management’s active cost containment efforts.

 

Research and Development Expense

 

Research and development expense decreased by $840 thousand for the quarter ended September 30, 2022, compared to the comparable period in the prior year. Non-cash share-based compensation expense allocated to research and development personnel was $172 thousand for the quarter ended September 30, 2022 comparable to the $210 thousand  for the prior period. Salaries and burden costs for the quarter ended September 30, 2022 increased $45 thousand compared to the prior year primarily associated with product development. Prototype related costs for quarter ended September 30, 2022, increased $105 thousand related to BolaWrap 150 continued improvements. We expect our research and development costs to remain at comparable levels for the balance of 2022. 

 

Operating Loss

 

Loss from operations during the three months ended September 30, 2022, of $3.9 million was a reduction of $2.1 million compared to that of the three months ended September 30, 2021 reflecting increased margin and the focus on reducing operating costs.

 

 

Nine months Ended September 30, 2022 Compared to Nine months Ended September 30, 2021

 

The following table sets forth for the periods indicated certain items of our condensed consolidated statement of operations. The financial information and the discussion below should be read in conjunction with the financial statements and notes contained in this Report.

 

   

Nine months Ended

September 30,

   

Change

 
   

2022

   

2021

   

$

   

%

 
   

(in thousands, except percentage change)

 

Revenues:

                               

Product sales

  $ 4,042     $ 4,997     $ (955 )     (19 %)

Other revenue

    422       283       139       49 %

Total revenues

    4,464       5,280       (816 )     (15 %)

Cost of revenues:

                               

Products and services

    2,430       3,276       (846 )     (26 %)

Restructuring inventory charge

    -       747       (747 )     -  

Total cost of revenues

    2,430       4,023       (1,593 )     (40 %)
                                 

Gross profit

    2,034       1,257       777       62 %
                                 

Operating expenses:

                               

Selling, general and administrative

    11,952       16,210       (4,258 )     (26 %)

Research and development

    4,210       4,303       (93 )     (2 %)

Total operating expenses

    16,162       20,513       (4,351 )     (21 %)

Loss from operations

  $ (14,128 )   $ (19,256 )   $ 5,128       (27 %)

 

Revenue

 

We reported net revenue of $4.5 million for the nine months ended September 30, 2022, as compared to $5.3 million for the quarter ended September 30, 2021. Domestic revenues of $3.5 million for the nine months reflected growth of 23% over the prior comparable quarter of $2.8 million. International revenues decreased from $2.4 million for the nine months ended September 30, 2021 to $1.0 million for the nine months ended September 30, 2022. We incurred discounts of $790 thousand during the nine months ended September 30, 2022, primarily as a result of promotional programs designed to encourage domestic customers to upgrade to the BolaWrap 150. The discounts compare to business discounts of $161 thousand in the comparable nine-month period of the prior year. We expect selected discounts in the fourth quarter but thereafter a decline to minimal discounts as we have phased out our promotional upgrade offer.

 

International revenues generally consist of larger orders with the end user being large, centralized government agencies. These orders continue to be lumpy and difficult to predict as to both timing and amount. International orders anticipated in the second quarter were delayed due to the change over from the BolaWrap 100 but those orders for BolaWrap 150 are anticipated in future quarters. We believe that revenue during the fiscal year 2022 will still be an increase compared to the revenue recorded during 2021 due to growth of domestic sales and anticipated international orders from a robust pipeline, although no assurances can be given.

 

We incurred product promotional costs of $616 thousand during the nine months ended September 30, 2022, related primarily to BolaWrap 150 demonstration products and the cost of training products and accessories delivered to law enforcement agencies that were expensed as marketing costs. A total of $816 thousand of product promotional costs were incurred during the nine months ended September 30, 2021. We are responding to increased demand for training as a result of expanded product and brand awareness with more efficient training approaches. With increased successful field use by agencies and greater brand awareness we expect reductions in product promotional costs to decline versus the prior year.

 

We had $300 thousand of deferred revenue at September 30, 2022, of which $177 thousand related to VR training and $123 thousand related to BolaWrap extended warranties and services.

 

At September 30, 2022, we had backlog of $26 thousand worth of customer orders expected to be delivered in the next twelve months. Distributor and customer orders for future deliveries are generally subject to modification, rescheduling or in some instance’s cancellation in the normal course of business.

 

 

Gross Profit

 

Our cost of revenue for the nine months ended September 30, 2022, was $2.4 million resulting in a gross margin of 46%. The gross margin for the nine months ended September 30, 2021, was 38% after adjusting excluding $747 thousand of restructuring charges related to the wind down of BolaWrap 100 production. The most recent period gross margin was impacted by the lower sales volume and promotional discounts. We also were impacted by certain higher raw material prices in 2022 to obtain certain parts. Our margin is expected to improve in future quarters as these issues abate.

 

Due to our limited history of revenue historical margins, however, may not be indicative of planned future margins. The BolaWrap 150 has higher margins than historical production. Our margins also vary based on the sales channels through which our products are sold and product mix. Currently, our cassettes have lower margins than BolaWrap devices. We implement product updates and revisions, including raw material and component changes that may impact product costs. With such product updates and revisions, we have limited warranty cost experience and estimated future warranty costs can impact our gross margins.

 

Our global supply chain has been subject to component shortages, increased lead times, cost fluctuations, and logistics constraints that have impacted our product costs. We expect these supply chain challenges to continue throughout 2022. Supplier shortages, quality issues and logistic delays affect our production schedules and could in turn have a material adverse effect on our financial condition, results of operation and cash flows.

 

Selling, General and Administrative Expense

 

Selling, general and administrative (SG&A”) expense for the nine months ended September 30, 2022 were $12.0 million reflecting a decrease of $4.2 million when compared to $16.2 million for the nine months ended September 30, 2021. The reduction in SG&A costs reflected active cost containment efforts and nonrecurrence of certain one-time costs in the prior year period.

 

Share-based compensation costs allocated to SG&A was $2.2 million for the nine months ended September 30, 2022 compared to $3.7 million for the comparable prior year period. This $1.5 million decrease resulted primarily from  reduced headcount and changes in the stock price.

 

Salaries and burden costs of $6.8 million for the nine months ended September 30, 2022 was a $2.8 million decrease compared to the prior year nine months due to cost containment efforts and reduced personnel expense. During the nine months ended September 30, 2022, as compared to the prior year comparable nine months, we incurred reduced advertising and promotions costs (including product promotion costs) of $460 thousand, reduced professional fees of $155 thousand, and reduced consulting and contract services fees of $652 thousand. We expect expenditures for SG&A expense for the balance of 2022 to remain below the prior year due to active cost containment efforts.

 

Research and Development Expense

 

Research and development expense decreased by $93 thousand for the nine months ended September 30, 2022, compared to the comparable nine-month period in fiscal 2021. Non-cash share-based compensation expense allocated to research and development personnel was $448 thousand for the nine months ended September 30, 2022 compared to the $588 thousand for the prior period. Salaries and burden costs for the nine months ended September 30, 2022 was $2.5 million are in line with the prior year period. Prototype related costs for the nine months ended September 30, 2022, increased $359 thousand related to BolaWrap 150 startup costs and continued improvements.

 

Operating Loss

 

Loss from operations during the nine months ended September 30, 2022, of $14.1 million was a reduction of $5.1 million compared to that of the nine months ended September 30, 2021 reflecting third quarter reduced costs from the prior year.

 

 

Liquidity and Capital Resources

 

Overview

 

We have experienced net losses and negative cash flows from operations since our inception. As of September 30, 2022, we had cash and cash equivalents of $3.8 million, short-term investments of $19.9 million, positive working capital of $27.3 million and had sustained cumulative losses attributable to stockholders of $63.8 million. We believe that our cash on hand and short-term investments will sustain our operations for at least the next twelve months.

 

 

Our primary source of liquidity to date has been funding from our stockholders from the sale of equity securities and the exercise of derivative securities, consisting of options and warrants. We expect our primary source of future liquidity will be from the sale of products, exercise of stock options and warrants and if required from future equity or debt financings.

 

Capital Requirements

 

Due in part to the volatility caused by COVID-19, we do not have a high degree of confidence in our estimates for our future liquidity requirements or future capital needs, which will depend on, among other things, capital required to introduce new products and the operational staffing and support requirements, as well as the timing and amount of future revenue and product costs. We anticipate that demands for operating and working capital may grow depending on decisions on staffing, development, production, marketing, training and other functions and based on other factors outside of our control. We believe we have sufficient capital to sustain our operations for the next twelve months.

 

Our future capital requirements, cash flows and results of operations could be affected by, and will depend on, many factors, some of which are currently unknown to us, including, among other things:

 

 

The impact and effects of the global outbreak of the COVID-19 pandemic, and other potential pandemics or contagious diseases or fear of such outbreaks;

 

Decisions regarding staffing, development, production, marketing and other functions;

 

The timing and extent of market acceptance of our products;

 

Costs, timing and outcome of planned production and required customer and regulatory compliance of our products;

 

Costs of preparing, filing and prosecuting our patent applications and defending any future intellectual property-related claims;

 

Costs and timing of additional product development;

 

Costs, timing and outcome of any future warranty claims or litigation against us associated with any of our products;

 

Ability to collect accounts receivable; and

 

Timing and costs associated with any new financing.

 

Principal factors that could affect our ability to obtain cash from external sources including from exercise of outstanding warrants and options include:

 

 

Volatility in the capital markets; and

 

Market price and trading volume of our Common Stock.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Cash Flow

 

Operating Activities

 

During the nine months ended September 30, 2022, net cash used in operating activities was $11 million. The net loss of $14.1 million was decreased by non-cash expense of $3.4 million consisting primarily of share-based compensation expense of $2.6 million. Other major component changes using operating cash included an increase of $1.4 million in inventories and a net reduction in accounts payable and accrued liabilities of $659 thousand. A decrease in accounts receivable of $1.6 million reduced the cash used in operating activities.

 

 

During the nine months ended September 30, 2021, net cash used in operating activities was $13.7 million. The net loss of $19.2 million was decreased by non-cash expense of $5.9 million consisting primarily of share-based compensation expense of $4.3 million, restructuring inventory charges of $747 thousand, depreciation and amortization expense of $336 thousand and shares issued for services of $239 thousand. Other major component changes using operating cash included an increase of $1.4 million in accounts receivable and an increase in inventories of $160 thousand. An increase of $773 thousand in accounts payable and accrued expense and an increase of $224 thousand in deferred revenue reduced the cash used in operating activities. 

 

Investing Activities

 

During the nine months ended September 30, 2022, we used $23.1 million of cash to purchase short-term investments and we had proceeds from maturities of short-term investments of $33.3 million. During the nine months ended September 30, 2021, we used $30.0 million of cash to purchase short-term investments and we had proceeds from maturities of short-term investments of $25 million. 

 

We used $201 thousand and $811 thousand of cash for the purchase of property and equipment during the nine months ended September 30, 2022, and 2021, respectively. We invested $133 thousand and $129 thousand in patents during the nine months ended September 30, 2022, and 2021, respectively.

 

Financing Activities

 

During the nine months ended September 30, 2022, we received $83 thousand in proceeds from the exercise of previously issued stock options.

 

During the nine months ended September 30, 2021, we received $12.0 million from previously issued stock purchase warrants and $1.7 million in proceeds from the exercise of previously issued stock options, and repaid $275 thousand in debt relating to the acquisition of NSENA in December 2020.

 

Contractual Obligations and Commitments

 

Pursuant to that certain exclusive Amended and Restated Intellectual Property License Agreement dated September 30, 2016, by and between the Company and Syzygy Licensing, LLC (“Syzygy”), we are obligated to pay to Syzygy a 4% royalty fee on future product sales up to an aggregate amount of $1.0 million in royalty payments or until September 30, 2026, whichever occurs earlier.

 

We are committed to aggregate lease payments on our facility lease of $31 thousand in 2022, $121 thousand in 2023, $125 thousand in 2024, and $75 thousand in 2025.

 

At September 30, 2022, we were committed for approximately $4.4 million for future component deliveries and contract services that are generally subject to modification or rescheduling in the normal course of business.

 

Effects of Inflation

 

We do not believe that inflation has had a material impact on our business, revenue or operating results during the periods presented.

 

Recent Accounting Pronouncements

 

There have been no recent accounting pronouncements or changes in accounting pronouncements during the period ended September 30, 2022, or subsequently thereto, that we believe are of potential significance to our financial statements.

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not applicable.

 

 

Item 4. Controls and Procedures.

 

We are required to maintain disclosure controls and procedures designed to ensure that material information related to us, including our consolidated subsidiaries, is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, as of September 30, 2022, we conducted an evaluation of our disclosure controls and procedures as such term is defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting during our fiscal quarter ended September 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Our process for evaluating controls and procedures is continuous and encompasses constant improvement of the design and effectiveness of established controls and procedures and the remediation of any deficiencies, which may be identified during this process.

 

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future period are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

Shareholder Derivative Litigation

 

On November 13, 2020, Naresh Rammohan filed a shareholder derivative action in the United States District Court for the Central District of California against current and former Company officers Tom Smith, James Barnes, Mike Rothans, Marc Thomas, and David Norris, as well as current and former Company directors Messrs. Scot Cohen, Patrick Kinsella, Michael Parris, and Wayne Walker, alleging unjust enrichment, breach of fiduciary duty, waste of corporate assets, and contribution claims under the Securities Exchange Act of 1934, docketed as Case No. 2:20-cv-10444-DMG-PVCx. On January 20, 2021, Ray Westerman filed a second derivative action in the same court against the same parties, alleging breach of fiduciary duty and contribution claims under the Securities Exchange Act of 1934, docketed as Case No. 2:21-cv-00550-DMG-PVCx. On January 22, 2021, Jesse Lowe filed a third derivative action in the same court against the same parties, alleging breach of fiduciary duty and asserting various claims under the Securities Exchange Act of 1934, docketed as Case No. 2:21-cv-00597-DMG-PVCx. The Company was named as a nominal defendant in each of these actions.

 

On February 16, 2021, the Honorable Dolly M. Gee issued an order consolidating the three derivative actions under the caption In re Wrap Technologies, Inc. Shareholder Derivative Litigation, Case No. 2:20-10444-DMG-PVCx, (the “Derivative Action”) and stayed the Derivative Action at least until the resolution of the action captioned In re Wrap Technologies, Inc. Securities Exchange Act Litigation, Case No. 2:20-cv-08760-DMG (the “Securities Action”).  On December 20, 2021, Judge Gee dismissed the Securities Action with prejudice.  On April 29, 2022 the above-mentioned parties jointly filed a stipulation of voluntary dismissal in order to dismiss the Derivative Action without prejudice to the plaintiffs, the Company, or Wrap shareholders (“the Stipulation”). The Stipulation was granted by Judge Gee on May 3, 2022. 

 

 

Other Legal Information

 

We may become subject to other legal proceedings, as well as demands and claims that arise in the normal course of our business, including claims of alleged infringement of third-party patents and other intellectual property rights, breach of contract, employment law violations, and other matters and matters involving requests for information from us or our customers under federal or state law. Such claims, even if not meritorious, could result in the expenditure of significant financial and management resources. We make a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed and adjusted to include the impacts of negotiations, estimated settlements, legal rulings, advice of legal counsel, and other information and events pertaining to a particular matter. At September 30, 2022, we had no provision for liability under existing litigation.

 

An unfavorable outcome on any litigation matters could require payment of substantial damages, or, in connection with any intellectual property infringement claims, could require us to pay ongoing royalty payments or could prevent us from selling certain of our products. As a result, a settlement of, or an unfavorable outcome on, any of the matters referenced above or other litigation matters, or legal proceedings could have a material adverse effect on our business, operating results, financial condition and cash flows.

 

Item 1A. Risk Factors

 

Management is not aware of any material changes to the risk factors discussed in Part 1, Item 1A, of the Annual Report on Form 10-K for the year ended December 31, 2021.  In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors discussed in Part 1, Item 1A, of the Annual Report on Form 10-K for the year ended December 31, 2021, and subsequent reports filed pursuant to the Exchange Act which could materially and adversely affect the Companys business, financial condition, results of operations, and stock price. The risks described in the Annual Report on Form 10-K and subsequent reports filed pursuant to the Exchange Act are not the only risks facing the Company. Additional risks and uncertainties not presently known to management, or that management presently believes not to be material, may also result in material and adverse effects on our business, financial condition, and results of operations.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

No unregistered securities were issued during the three months ended September 30, 2022, that were not previously reported.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

Exhibit 10.1 

Letter Agreement by and between Wrap Technologies, Inc. and Chris DeAlmeida, executed July 20, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on July 25, 2022).

Exhibit 10.2

Transition Agreement and Release of Claims, dated July 24, 2022, by and between Wrap Technologies, Inc. and James Barnes (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on July 25, 2022).

Exhibit 31.1

Certification of TJ Kennedy, Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

Exhibit 31.2

Certification of Chris DeAlmeida, Principal Accounting Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

Exhibit 32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by TJ Kennedy, Principal Executive Officer, and Chris DeAlmeida, Principal Accounting Officer.*

   
 

Extensible Business Reporting Language (XBRL) Exhibits*

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (embedded within the Inline XBRL Document and include in Exhibit 101)

 

* Filed concurrently herewith

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

  WRAP TECHNOLOGIES, INC.
   

 

By:

/s/ CHRIS DEALMEIDA
November 9, 2022  
   

Chris DeAlmeida

Chief Financial Officer and Treasurer

(Principal Accounting Officer)

 

-30-
EX-31.1 2 ex_442157.htm EXHIBIT 31.1 ex_442157.htm

Exhibit 31.1

 

CERTIFICATION

 

I, TJ Kennedy, certify that:

 

1.         I have reviewed this quarterly report on Form 10-Q of Wrap Technologies, Inc.;

 

2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 9, 2022

 

/s/ TJ KENNEDY                           

TJ Kennedy

Chief Executive Officer

(Principal Executive Officer)

 

 
EX-31.2 3 ex_442158.htm EXHIBIT 31.2 ex_442158.htm

Exhibit 31.2

 

CERTIFICATION

 

I, Chris DeAlmeida, certify that:

 

1.         I have reviewed this quarterly report on Form 10-Q of Wrap Technologies, Inc.;

 

2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: November 9, 2022

 

/s/ CHRIS DEALMEIDA

Chris DeAlmeida

Chief Financial Officer and Treasurer

(Principal Accounting Officer)

 

 
EX-32.1 4 ex_442159.htm EXHIBIT 32.1 ex_442159.htm

Exhibit 32.1

 

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Each of the undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his or her capacity as an officer of Wrap Technologies, Inc. (the “Company”), that, to his or her knowledge, the Quarterly Report of the Company on Form 10-Q for the period ended September 30, 2022, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: November 9, 2022

 

/s/ TJ KENNEDY                  

TJ Kennedy

Chief Executive Officer

(Principal Executive Officer)

 

Date: November 9, 2022

 

/s/ CHRIS DEALMEIDA

Chris DeAlmeida

Chief Financial Officer and Treasurer

(Principal Accounting Officer)

 

 

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 
EX-101.SCH 5 wrap-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited)-parentheticals link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited)-parentheticals (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)-parentheticals link:calculationLink link:definitionLink link:presentationLink 007 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)-parentheticals (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 008 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 2 - Revenue and Product Costs link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 3 - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 4 - Inventories, Net link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 5 - Property and Equipment, Net link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 6 - Intangible Assets, Net link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 8 - Lease link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 9 - Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 10 - Share-based Compensation link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 11 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 12 - Related Party Transactions link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 13 - Major Customers and Related Information link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 14 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 2 - Revenue and Product Costs (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 3 - Fair Value Measurements (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 4 - Inventories, Net (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 5 - Property and Equipment, Net (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 6 - Intangible Assets, Net (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 8 - Lease (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 10 - Share-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 13 - Major Customers and Related Information (Tables) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 2 - Revenue and Product Costs (Details Textual) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 2 - Revenue and Product Costs - Contract Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 3 - Fair Value Measurements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 3 - Fair Value Measurements - Instruments by Significant Investment Category (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 4 - Inventories, Net - Summary of Inventories (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 5 - Property and Equipment, Net (Details Textual) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 6 - Intangible Assets, Net (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 6 - Intangible Assets, Net - Summary of Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 6 - Intangible Assets, Net - Future Amortization Expense (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities - Summary of Accrued Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 8 - Lease (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 8 - Lease - Summary of Operating Lease Obligations (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 8 - Lease - Future Lease Payments (Details) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 9 - Stockholders' Equity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 10 - Share-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 10 - Share-based Compensation - Summary of RSU Activity (Details) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expen